Folgen
Judith Gottwein
Judith Gottwein
Professor. University of Copenhagen. Copenhagen University Hospital Hvidovre.
Bestätigte E-Mail-Adresse bei gottwein.eu
Titel
Zitiert von
Zitiert von
Jahr
Development and characterization of hepatitis C virus genotype 1‐7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs
JM Gottwein, TKH Scheel, TB Jensen, JB Lademann, JC Prentoe, ...
Hepatology 49 (2), 364-377, 2009
4342009
Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses
JM Gottwein, TKH Scheel, AM Hoegh, JB Lademann, J Eugen–Olsen, ...
Gastroenterology 133 (5), 1614-1626, 2007
2432007
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization
TKH Scheel, JM Gottwein, TB Jensen, JC Prentoe, AM Hoegh, HJ Alter, ...
Proceedings of the National Academy of Sciences 105 (3), 997-1002, 2008
2342008
MicroRNA-122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR
YP Li, JM Gottwein, TK Scheel, TB Jensen, J Bukh
Proceedings of the National Academy of Sciences 108 (12), 4991-4996, 2011
2312011
p-ANCAs in autoimmune liver disorders recognise human β-tubulin isotype 5 and cross-react with microbial protein FtsZ
B Terjung, J Söhne, B Lechtenberg, J Gottwein, M Muennich, V Herzog, ...
Gut 59 (6), 808-816, 2010
1922010
Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization
J Prentoe, TB Jensen, P Meuleman, SBN Serre, TKH Scheel, ...
Journal of virology 85 (5), 2224-2234, 2011
1672011
Recombinant HCV variants with NS5A from genotypes 1–7 have different sensitivities to an NS5A inhibitor but not interferon-α
TKH Scheel, JM Gottwein, LS Mikkelsen, TB Jensen, J Bukh
Gastroenterology 140 (3), 1032-1042. e6, 2011
1622011
Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses
JM Gottwein, TKH Scheel, TB Jensen, L Ghanem, J Bukh
Gastroenterology 141 (3), 1067-1079, 2011
1552011
Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system
YP Li, S Ramirez, SB Jensen, RH Purcell, JM Gottwein, J Bukh
Proceedings of the National Academy of Sciences 109 (48), 19757-19762, 2012
1492012
Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells
M Saeed, TKH Scheel, JM Gottwein, S Marukian, LB Dustin, J Bukh, ...
Antimicrobial agents and chemotherapy 56 (10), 5365-5373, 2012
1442012
Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies
JM Gottwein, TKH Scheel, B Callendret, YP Li, HB Eccleston, RE Engle, ...
Journal of virology 84 (10), 5277-5293, 2010
1422010
Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems
JM Gottwein, J Bukh
Advances in virus research 71, 51-133, 2008
1382008
Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection
TB Jensen, JM Gottwein, TKH Scheel, AM Hoegh, J Eugen-Olsen, J Bukh
The Journal of infectious diseases 198 (12), 1756-1765, 2008
1332008
Protective Anti‐Helicobacter Immunity Is Induced with Aluminum Hydroxide or Complete Freund’s Adjuvant by Systemic Immunization
JM Gottwein, TG Blanchard, OS Targoni, JC Eisenberg, BM Zagorski, ...
The Journal of infectious diseases 184 (3), 308-314, 2001
1202001
Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus
JC Meunier, JM Gottwein, M Houghton, RS Russell, SU Emerson, J Bukh, ...
Journal of Infectious Diseases 204 (8), 1186-1190, 2011
1162011
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
Y Zhou, KA Gammeltoft, LA Ryberg, LV Pham, HD Tjørnelund, A Binderup, ...
Science Advances 8 (51), eadd7197, 2022
1142022
Efficacy of NS5A inhibitors against hepatitis C virus genotypes 1–7 and escape variants
JM Gottwein, LV Pham, LS Mikkelsen, L Ghanem, S Ramirez, TKH Scheel, ...
Gastroenterology 154 (5), 1435-1448, 2018
1092018
Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains
YP Li, S Ramirez, JM Gottwein, TKH Scheel, L Mikkelsen, RH Purcell, ...
Proceedings of the National Academy of Sciences 109 (18), E1101-E1110, 2012
1052012
Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified …
JM Gottwein, TB Jensen, CK Mathiesen, P Meuleman, SBN Serre, ...
Journal of virology 85 (17), 8913-8928, 2011
932011
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2
Y Zhou, K Gilmore, S Ramirez, E Settels, KA Gammeltoft, LV Pham, ...
Scientific Reports 11 (1), 14571, 2021
882021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20